Cargando...
Effects of the Histone Deacetylase Inhibitor ITF2357 in Autoinflammatory Syndromes
We explored the effects of the oral histone deacetylase (HDAC) inhibitor ITF2357 in patients with autoinflammatory syndrome. In this prospective open-label pilot study, eight patients were enrolled; one patient with tumor necrosis factor receptor–associated periodic syndrome (TRAPS), three patients...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
ScholarOne
2011
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3105134/ https://ncbi.nlm.nih.gov/pubmed/21274502 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00039 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|